Literature DB >> 11160214

A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum.

G Diedrich1, N Bangia, M Pan, P Cresswell.   

Abstract

Heterodimers of MHC class I glycoprotein and beta(2)-microglobulin (beta(2)m) bind short peptides in the endoplasmic reticulum (ER). Before peptide binding these molecules form part of a multisubunit loading complex that also contains the two subunits of the TAP, the transmembrane glycoprotein tapasin, the soluble chaperone calreticulin, and the thiol oxidoreductase ERp57. We have investigated the assembly of the loading complex and provide evidence that after TAP and tapasin associate with each other, the transmembrane chaperone calnexin and ERp57 bind to the TAP-tapasin complex to generate an intermediate. These interactions are independent of the N:-linked glycan of tapasin, but require its transmembrane and/or cytoplasmic domain. This intermediate complex binds MHC class I-beta(2)m dimers, an event accompanied by the loss of calnexin and the acquisition of calreticulin, generating the MHC class I loading complex. Peptide binding then induces the dissociation of MHC class I-beta(2)m dimers, which can be transported to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160214     DOI: 10.4049/jimmunol.166.3.1703

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules.

Authors:  Antony N Antoniou; Stuart Ford; Magnus Alphey; Andrew Osborne; Tim Elliott; Simon J Powis
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens.

Authors:  Anne L Ackerman; Christoph Kyritsis; Robert Tampé; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-15       Impact factor: 11.205

4.  Separate roles and different routing of calnexin and ERp57 in endoplasmic reticulum quality control revealed by interactions with asialoglycoprotein receptor chains.

Authors:  Zehavit Frenkel; Marina Shenkman; Maria Kondratyev; Gerardo Z Lederkremer
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

Review 5.  Functional regulation of immunoproteasomes and transporter associated with antigen processing.

Authors:  L Y Hwang; P T Lieu; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition.

Authors:  Jean-Manuel Segura; Philippe Guillaume; Silke Mark; Danijel Dojcinovic; Alexandre Johannsen; Giovanna Bosshard; Georgi Angelov; Daniel F Legler; Horst Vogel; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

7.  Folding of thyroglobulin in the calnexin/calreticulin pathway and its alteration by loss of Ca2+ from the endoplasmic reticulum.

Authors:  Bruno Di Jeso; Luca Ulianich; Francesco Pacifico; Antonio Leonardi; Pasquale Vito; Eduardo Consiglio; Silvestro Formisano; Peter Arvan
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

8.  Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assembly.

Authors:  Naveen Bangia; Peter Cresswell
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 9.  Potential functional role of plasmacytoid dendritic cells in cancer immunity.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Koji Arihiro
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

Review 10.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.